Search PubMedSearch

PubMed · 6887128

Repeat prescriptions.

Abstract

Ninety-six general practitioner recorders undertook an average of 308 consultations in the two weeks reviewed, equivalent to 121 consultations per 1,000 registered patients on the list. The number of patients to whom repeat prescriptions were issued was 10,225.The mean rate of issue of repeat prescriptions was 41.9 per 1,000 list, (346 per 1,000 consultations) though these figures conceal a wide variation between the recorders, 41 per cent of recipients were aged 65+ years and 20 per cent had not been seen by their doctor in the six months prior to receipt. The repeat prescribing rate of individual doctors bears no relation to the workload as measured by the number of consultations undertaken.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D M Fleming. 1983. Repeat prescriptions.. https://pubmed.ncbi.nlm.nih.gov/6887128/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Measuring switchability and prescribability: when is average bioequivalence sufficient?

Recent work, beginning with that of Anderson and Hauck in 1990, has led to a general acceptance of the need to ensure switchability in bioequivalence testing for approval of generic drugs. In other applications of bioequivalence testing, prescribability may be sufficient. However, there is less acceptance of the need to change statistical procedures and study designs from those currently used to assess the current criterion of average bioequivalence. We propose easily interpreted measures of switchability and prescribability. These measures provide bases for assessing conditions under which average bioequivalence is not sufficient to ensure switchability and prescribability, and hence for which a procedure for individual or population bioequivalence is required. The required conditions are sufficiently tight that they cannot be presumed to hold. Thus, there are reasonable conditions for which current practice is not sufficient. An outcome of this development is a connection between two current approaches for assessing individual bioequivalence.

Drug Prescriptions